GoKawiil
Gilead Sciences Swings to Loss on R&D Costs as HIV-Drug Sales Lift Revenue
(feeds.content.dowjones.io)
1.
2.
Sino Biopharm Strikes Drug Licensing Deal With AstraZeneca, Deepens GSK Partnership
(feeds.content.dowjones.io)
3.
AstraZeneca, Sino Biopharm Sign Up to $1.9 Billion Respiratory Drug Licensing Deal
(feeds.content.dowjones.io)
4.
AbbVie to Buy Apogee Therapeutics for $10.9 Billion in Cash
(feeds.content.dowjones.io)
5.
Incyte to Buy Vega Therapeutics For Up to $2 Billion
(feeds.content.dowjones.io)
6.
Gilead Sciences to Buy Clinical-Stage Biotech Tubulis for Up to $5 Billion
(feeds.content.dowjones.io)
7.
Novocure Gets FDA Approval for Pancreatic Cancer Treatment; Shares Soar
(feeds.content.dowjones.io)
8.
Gilead Sciences Profit Rises on Growth of Liver Disease, HIV Products
(feeds.content.dowjones.io)